Gem Diamonds Limited
20 February 2008
Gem Diamonds Ltd
Allotment and Issue of Ordinary Shares to Non-Executive Directors
On 19th February 2008, the Board of Directors of Gem Diamonds Limited ('Gem
Diamonds' or the 'Company') met and formally approved the allotment and issue of
506,322 ordinary shares in the capital of the Company ('Ordinary Shares') to
four of the Company's Non-Executive Directors on the terms set out in the
Prospectus published by the Company on 14 February 2007 and outlined in more
detail below. The Ordinary Shares will be subscribed for at a nominal value of
US$0.01 each.
Application has been made to the FSA and the London Stock Exchange for listing
and trading of the shares as at 25th February 2008.
Non-Executive Director Number of Ordinary Shares
Roger Davis (2nd tranche) 289,326
Gavin Beevers (2nd tranche) 72,332
Dave Elzas (2nd tranche) 72,332
Mike Salamon (1st tranche) 72,332
For further information:
Gem Diamonds Limited
Tel: 020 3043 0280
Andre Confavreux
Company Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.